DCH Auriga - Healthcare
Four Star
Zuellig
iNova
Ipsen

PATHEON INC

Featured products of Patheon
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
naltrexone hydrochloride, bupropion hydrochloride
Packing/Price
112's
MIMS Class
Anti-Obesity Agents
ATC Classification
A08AA62 - bupropion and naltrexone : Belongs to the class of centrally acting antiobesity products. Used in the treatment of obesity.
cenobamate
Packing/Price
(titration pack) 28's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
cenobamate
Packing/Price
30's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cenobamate
Packing/Price
(titration pack) 28's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
cenobamate
Packing/Price
30's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
Distributed by Four Star
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Distributed by Zuellig
naltrexone hydrochloride, bupropion hydrochloride
Packing/Price
112's
MIMS Class
Anti-Obesity Agents
ATC Classification
A08AA62 - bupropion and naltrexone : Belongs to the class of centrally acting antiobesity products. Used in the treatment of obesity.
Marketed by iNova
naltrexone hydrochloride, bupropion hydrochloride
Packing/Price
112's
MIMS Class
Anti-Obesity Agents
ATC Classification
A08AA62 - bupropion and naltrexone : Belongs to the class of centrally acting antiobesity products. Used in the treatment of obesity.
Marketed by Ipsen
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in